Perspective: Lessons learned from molecular genetic studies of thyroid cancer - Insights into pathogenesis and tumor-specific therapeutic targets

Endocrinology

Volumn 143, Issue 6, 2002, Pages 2025-2028

  Fagin, James A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; MEMBRANE RECEPTOR; PROTEIN RET; TYROSINE KINASE RECEPTOR;

CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; DNA DAMAGE; ENZYME STRUCTURE; GENE MUTATION; GENE REARRANGEMENT; HUMAN; IONIZING RADIATION; MOLECULAR GENETICS; NONHUMAN; ONCOCYTOMA; ONCOGENE K RAS; PATHOGENESIS; PRIORITY JOURNAL; RADIATION EXPOSURE; RECEPTOR GENE; THYROID CANCER; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR CLASSIFICATION;

EID: 0036098222     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.6.8832     Document Type: Conference Paper

References (44)

1. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF
2. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas
3. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI α of cyclic AMP-dependent protein kinase A
4. The two genes generating RET/PTC3 are localized in chromosomal band 10q11.2
5. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma
6. A new form of RET rearrangement in thyroid carcinomas of children after the Chernobyl reactor accident
7. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5
8. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas
9. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma
10. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children
11. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident
12. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident
13. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation
14. RET/PTC oncogene activation is an early event in thyroid carcinogenesis
15. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice
16. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas
17. The RET/PTC3 oncogene: Metastatic solid-type papillary carcinomas in murine thyroids
18. In vitro irradiation is able to cause RET oncogene rearrangement
19. Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis
20. Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas
21. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells
22. Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene
23. Cancer mortality following treatment for adult hyperthyroidism
24. Thyroid cancer following exposure to radioactive iodine
25. Radioiodine-induced thyroid cancer: Studies in the aftermath of Chernobyl
26. Agent-specific ras oncogene activation in rat thyroid tumours
27. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia
28. Natural history of radiation-associated thyroid cancer
29. Familial adenomatous polyposis associated thyroid carcinoma: A distinct type of follicular cell neoplasm
30. Molecular basis off Hurthle cell papillary thyroid carcinoma
31. Tyrosine kinase inhibitors: From rational design to clinical trials
32. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
33. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
34. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
35. Inhibition of transforming activity of the ret/ptc1 oncoprotein by a 2-indolinone derivative
36. Specific inhibition of kinase activity of Ret oncoproteins and of Ret-induced cell growth by PKI166
37. PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma
38. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma
39. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
40. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: Evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1
41. Overexpression and overactivation of Akt in thyroid carcinoma
42. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex
43. Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex
44. Spectrum of malignancy and premalignancy in Carney syndrome